Recombinant ITGA2B, ITGB3 (Tadocizumab Biosimilar) antibody
Quick Overview for Recombinant ITGA2B, ITGB3 (Tadocizumab Biosimilar) antibody (ABIN7598016)
Target
Antibody Type
Reactivity
Host
Clonality
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Tadocizumab Biosimilar Antibody
-
Specificity
- CD41, ITGAB, GPIIb, ITGA2B, Platelet membrane glycoprotein IIb, GP2B, Integrin alpha-IIb, GPalpha IIb, GPIIIa, Integrin beta-3, CD61, ITGB3, Platelet membrane glycoprotein IIIa, GP3A
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- ITGA2B, ITGB3 (Tadocizumab Biosimilar)
-
Alternative Name
- Tadocizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- CD41, ITGAB, GPIIb, ITGA2B, Platelet membrane glycoprotein IIb, GP2B, Integrin alpha-IIb, GPalpha IIb, GPIIIa, Integrin beta-3, CD61, ITGB3, Platelet membrane glycoprotein IIIa, GP3A
-
UniProt
- P08514, P05106
-
CAS-No
- 339086-80-5
Target
-